Mechanisms of Normalisation of Bone Metabolism during Recovery from Hyperthyroidism: Potential Role for Sclerostin and Parathyroid Hormone
Sclerostin, a protein expressed by osteocytes, is a negative regulator of bone formation. The aim of the study was to investigate the relationship between parathyroid hormone (PTH) and markers of bone metabolism and changes of sclerostin concentrations before and after treatment of hyperthyroidism....
Saved in:
| Main Authors: | Elżbieta Skowrońska-Jóźwiak, Krzysztof C. Lewandowski, Zbigniew Adamczewski, Kinga Krawczyk-Rusiecka, Andrzej Lewiński |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/948384 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Progress in diagnosis and treatment of hypothalamic & pituitary disorders
by: Krzysztof C. Lewandowski, et al.
Published: (2025-08-01) -
Sclerostin
by: Stuart L. Silverman
Published: (2010-01-01) -
Parathyroid Hormone Fluctuations During Thyroid and Parathyroid Surgery
by: Emily S. Sagalow, et al.
Published: (2025-01-01) -
Role of sclerostin in mastocytosis bone disease
by: Aneta Szudy-Szczyrek, et al.
Published: (2025-01-01) -
Research progress on the role of parathyroid hormone and parathyroid hormone-related peptide in regulating tooth eruption
by: LUO Qian, HU Yushang, YANG Kun, GE Song, ZHONG Wenyi
Published: (2025-07-01)